Trials / Completed
CompletedNCT01828723
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells
A Phase One, Open Label, Single Arm Study to Demonstrate the Safety of Antria Cell Preparation Process During Facial Fat Grafting Assisted With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Antria · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to demonstrate the safety of injecting the Stromal Vascular Fraction (SVF) \[containing Adipose Derived Stem Cells (ADSCs)\] enriched fat grafts into regions of the face that require enhancement. The safety of SVF will be evaluated throughout the course of the study phase through the assessment of laboratory values, physical examinations, adverse events, safety phone calls etc.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | SVF |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2013-04-11
- Last updated
- 2015-01-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01828723. Inclusion in this directory is not an endorsement.